CME Group Inc.
CME Group Inc. (CME) — Form 144: Proposed sale of shares
AI-generated summary
Director Martin J Gepsman filed to propose the sale of 400 shares of CME Group Inc. Class A Common Stock with an aggregate market value of $121,000. The shares were originally acquired as Restricted Stock on June 25, 2026. The sale was scheduled for around October 22, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.
Key facts
- Seller
- MARTIN J GEPSMAN
- Relationship
- Director
- Shares to sell
- 400
- Market value
- $121,000.00
- Approximate sale date
- Oct 22, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Jun 25, 2026 · Restricted Stock
More CME filings
- 4
Filed Oct 27, 2026
- 144
Filed Oct 27, 2026
- 10-Q
Filed Oct 23, 2026
- 4
Filed Oct 22, 2026
- 8-K
Filed Oct 21, 2026
- 4
Filed Sep 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.